As per Intent Market Research, the Metal Non Covered Biliary Stent Market was valued at USD 1.2 billion and will surpass USD 2.2 billion by 2030; growing at a CAGR of 9.8% during 2024 - 2030.
The Metal Non-Covered Biliary Stent Market plays a crucial role in the management of biliary obstructions, a common complication in patients with liver diseases, cancer, and other gastrointestinal disorders. These stents are primarily used to restore bile flow in cases where the bile duct is blocked due to conditions such as malignant biliary strictures, benign biliary strictures, and pancreatic duct obstructions. The stents are typically made from stainless steel or nickel-titanium alloys, offering excellent durability, flexibility, and resistance to corrosion. The market for these stents is expanding as the incidence of bile duct obstructions rises globally, particularly in aging populations with an increased prevalence of related diseases like cancer and pancreatitis. With the growing demand for minimally invasive procedures in treating these conditions, metal non-covered biliary stents are increasingly being preferred due to their effectiveness in improving patient outcomes.
Self-Expanding Metal Biliary Stents Lead the Market Owing to Better Flexibility and Functionality
The self-expanding metal biliary stents segment is the largest within the metal non-covered biliary stent market, driven by their superior functionality, ease of placement, and clinical outcomes. Self-expanding stents are made from highly flexible materials like nickel-titanium alloys (commonly referred to as nitinol), which allow them to expand automatically once deployed inside the bile duct. This feature ensures a secure fit, reducing the need for manual adjustments during procedures, and provides a high degree of flexibility, which is essential for accommodating the natural anatomy of the bile duct. These stents are particularly effective in treating malignant biliary strictures and other complex cases, where the bile duct may be irregular or difficult to navigate.
Self-expanding stents are favored for their ability to withstand the mechanical forces within the biliary system, ensuring long-term patency and reducing the risk of obstruction. In addition, they can be used in a variety of applications, from biliary obstructions to pancreatic duct obstructions, making them a versatile solution in gastroenterological treatments. The increasing adoption of these stents, driven by their efficiency and enhanced patient safety, has positioned them as the leading subsegment in the metal non-covered biliary stent market.
Hospitals Dominate the End-Use Segment in the Metal Non-Covered Biliary Stent Market
Among the various end-use segments, hospitals account for the largest share of the metal non-covered biliary stent market. Hospitals are primary care centers where the majority of biliary obstruction treatments, including stent placements, are carried out. The increasing complexity of cases, such as those involving malignant biliary strictures and pancreatic duct obstructions, requires advanced medical technologies and highly skilled healthcare professionals, making hospitals the main setting for these procedures. The high patient volume, combined with the demand for effective treatment options, drives the widespread use of metal non-covered biliary stents in hospital settings.
Furthermore, the growing focus on minimally invasive surgeries in hospitals, aimed at reducing recovery times and improving patient outcomes, is propelling the demand for metal non-covered biliary stents. These stents are an integral part of endoscopic procedures, which are commonly performed in hospital settings, particularly in specialized gastroenterology and oncology departments. As hospitals continue to invest in advanced treatment technologies to meet the growing needs of patients with complex biliary conditions, the demand for metal non-covered biliary stents, particularly self-expanding models, is expected to remain strong.
North America Remains the Largest Region for Metal Non-Covered Biliary Stents
North America is the largest region in the metal non-covered biliary stent market, driven by advanced healthcare infrastructure, a high prevalence of diseases like pancreatic cancer and liver diseases, and a well-established market for medical devices. The region is home to some of the world’s leading healthcare facilities and research institutions, which adopt cutting-edge technologies to provide high-quality care for patients with biliary obstructions. Additionally, the rising number of endoscopic procedures performed in hospitals and specialty clinics is contributing to the growth of the market in North America.
The U.S., in particular, holds a significant share of the market, due to its aging population and high healthcare expenditure. With the increasing number of individuals requiring treatment for conditions such as malignant biliary strictures and biliary obstructions, the demand for effective and durable solutions like self-expanding metal biliary stents is expected to rise further. North America's focus on regulatory approvals, clinical advancements, and a growing preference for minimally invasive procedures ensures the continued dominance of the region in this market.
Leading Companies and Competitive Landscape
The metal non-covered biliary stent market is highly competitive, with key players focusing on product innovation and expanding their presence globally. Leading companies in the market include Boston Scientific, Cook Medical, Terumo Corporation, Medtronic, and Smith & Nephew, among others. These companies are continuously developing advanced stent technologies, such as self-expanding stents, to enhance patient outcomes and improve the efficiency of medical procedures.
In the highly competitive landscape, companies are focusing on strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to expand their product portfolios and gain market share. Additionally, these players are investing in research and development to enhance the performance of their biliary stents, ensuring they meet the evolving needs of healthcare providers and patients. As the market continues to grow, particularly in regions like North America, leading companies will continue to play a pivotal role in shaping the future of the metal non-covered biliary stent market.
Recent Developments:
- Boston Scientific Corporation launched a new line of self-expanding metal biliary stents designed for improved patient outcomes in the treatment of malignant biliary strictures.
- Medtronic PLC expanded its portfolio with a new nickel-titanium-based non-covered biliary stent aimed at providing longer patency for patients with benign biliary strictures.
- Cook Medical announced a partnership with a leading hospital network to enhance the distribution of its metal biliary stents across North America and Europe.
- Abbott Laboratories introduced an advanced version of its self-expanding biliary stent, designed for easier deployment and reduced complications in pancreatic duct obstruction cases.
- Olympus Corporation unveiled a new range of metal biliary stents with improved biocompatibility for use in challenging gastrointestinal and biliary procedures.
List of Leading Companies:
- Boston Scientific Corporation
- Medtronic PLC
- Cook Medical
- Abbott Laboratories
- Olympus Corporation
- Micro-Tech Endoscopy
- C.R. Bard (BD)
- ConMed Corporation
- Merit Medical Systems, Inc.
- Biotronik
- EndoChoice (Hoya Corporation)
- Teleflex Incorporated
- Richard Wolf GmbH
- Changzhou Healthcom Medical Device Co., Ltd.
- AngioDynamics
Report Scope:
Report Features |
Description |
Market Size (2023) |
USD 1.2 billion |
Forecasted Value (2030) |
USD 2.2 billion |
CAGR (2024 – 2030) |
9.8% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Metal Non Covered Biliary Stent Market By Type (Self-expanding Metal Biliary Stents, Balloon-expandable Metal Biliary Stents), By Material (Stainless Steel, Nickel-Titanium), By Application (Biliary Obstructions, Malignant Biliary Strictures, Benign Biliary Strictures, Pancreatic Duct Obstructions), By End-Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Boston Scientific Corporation, Medtronic PLC, Cook Medical, Abbott Laboratories, Olympus Corporation, Micro-Tech Endoscopy, C.R. Bard (BD), ConMed Corporation, Merit Medical Systems, Inc., Biotronik, EndoChoice (Hoya Corporation), Teleflex Incorporated, Richard Wolf GmbH, Changzhou Healthcom Medical Device Co., Ltd., AngioDynamics |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Metal Non Covered Biliary Stent Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Self-expanding Metal Biliary Stents |
4.2. Balloon-expandable Metal Biliary Stents |
5. Metal Non Covered Biliary Stent Market, by Material (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Stainless Steel |
5.2. Nickel-Titanium |
5.3. Other Alloys |
6. Metal Non Covered Biliary Stent Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Biliary Obstructions |
6.2. Malignant Biliary Strictures |
6.3. Benign Biliary Strictures |
6.4. Pancreatic Duct Obstructions |
7. Metal Non Covered Biliary Stent Market, by End-Use (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Hospitals |
7.2. Ambulatory Surgical Centers |
7.3. Specialty Clinics |
8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America Metal Non Covered Biliary Stent Market, by Type |
8.2.7. North America Metal Non Covered Biliary Stent Market, by Material |
8.2.8. North America Metal Non Covered Biliary Stent Market, by Application |
8.2.9. North America Metal Non Covered Biliary Stent Market, by End-Use |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US Metal Non Covered Biliary Stent Market, by Type |
8.2.10.1.2. US Metal Non Covered Biliary Stent Market, by Material |
8.2.10.1.3. US Metal Non Covered Biliary Stent Market, by Application |
8.2.10.1.4. US Metal Non Covered Biliary Stent Market, by End-Use |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Boston Scientific Corporation |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Medtronic PLC |
10.3. Cook Medical |
10.4. Abbott Laboratories |
10.5. Olympus Corporation |
10.6. Micro-Tech Endoscopy |
10.7. C.R. Bard (BD) |
10.8. ConMed Corporation |
10.9. Merit Medical Systems, Inc. |
10.10. Biotronik |
10.11. EndoChoice (Hoya Corporation) |
10.12. Teleflex Incorporated |
10.13. Richard Wolf GmbH |
10.14. Changzhou Healthcom Medical Device Co., Ltd. |
10.15. AngioDynamics |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Metal Non Covered Biliary Stent Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Metal Non Covered Biliary Stent Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Metal Non Covered Biliary Stent Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA